Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 1/2014

01-02-2014

Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study

Auteurs: D. Marrero, Q. Pan, E. Barrett-Connor, M. de Groot, P. Zhang, C. Percy, H. Florez, R. Ackermann, M. Montez, R. R. Rubin, the DPPOS Research Group

Gepubliceerd in: Quality of Life Research | Uitgave 1/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The purpose of this study is to assess if diagnosis of type 2 diabetes affected health-related quality of life (HRQoL) among participants in the Diabetes Prevention Program/Diabetes Prevention Program Outcome Study and changes with treatment or diabetes duration.

Methods

3,210 participants with pre-diabetes were randomized to metformin (MET), intensive lifestyle intervention (ILS), or placebo (PLB). HRQoL was assessed using the SF-36 including: (1) 8 SF-36 subscales; (2) the physical component (PCS) and mental component summary (MCS) scores; and (3) the SF-6D. The sample was categorized by diabetes free versus diagnosed. For diagnosed subgroup, mean scores in the diabetes-free period, at 6 months, 2, 4 and 6 years post-diagnosis, were compared.

Results

PCS and SF-6D scores declined in all participants in all treatment arms (P < .001). MCS scores did not change significantly in any treatment arm regardless of diagnosis. ILS participants reported a greater decrease in PCS scores at 6 months post-diagnosis (P < .001) and a more rapid decline immediately post-diagnosis in SF-6D scores (P = .003) than the MET or PLB arms. ILS participants reported a significant decrease in the social functioning subscale at 6 months (P < .001) and two years (P < .001) post-diagnosis.

Conclusions

Participants reported a decline in measures of overall health state (SF-6D) and overall physical HRQoL, whether or not they were diagnosed with diabetes during the study. There was no change in overall mental HRQoL. Participants in the ILS arm with diabetes reported a more significant decline in some HRQoL measures than those in the MET and PLB arms that developed diabetes.
vorige artikel Body mass index and health-related quality of life in apparently healthy individuals
volgende artikel A conceptual model of health-related quality of life in sarcoidosis
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.PubMedCrossRef
2.
Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ, 324(1417), 1.
3.
Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999). The impact of diagnosis of hepatitis c virus on quality of life. Hepatology, 30(5), 1299–1301.PubMedCrossRef
4.
Ketelaars, C. A., Schlösser, M. A., Mostert, R., Huyer, A.-S. H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 51, 39–43.PubMedCrossRef
5.
Sprangers, M. A. G., de Regt, E. B., Andries, F., van Agt, H. M., Bijl, R. V., de Boer, J. B., et al. (2000). Which chronic conditions are associated with better or poorer quality of life? Journal of Clinical Epidemiology, 53(9), 895–907.PubMedCrossRef
6.
Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2002). Impact of diabetes screening on quality of life. Diabetes Care, 25(6), 1022–1102.PubMedCrossRef
7.
Biondi, B., Palmieri, E. A., Fazio, S., Cosco, C., Nocera, M., Sacca, L., et al. (2000). Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701–4705.PubMed
8.
Helfand, M., & Redfern, C. C. (1998). Clinical guideline, part 2. Screening for thyroid disease: an update. Annals of Internal Medicine, 129, 144–158.PubMedCrossRef
9.
Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., et al. (1996). Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine, 11, 744–749.PubMedCrossRef
10.
Adriaanse, M. C., & Snoek, F. J. (2006). The psychological impact of screening for type 2 diabetes. Diabetes/Metabolism Research and Reviews, 22, 20–25.PubMedCrossRef
11.
Adriaanse, M. C., Dekker, J. M., Spijkerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21, 1075–1081.PubMedCrossRef
12.
Adriaanse, M. C., Snoek, F. J., Decker, J. M., et al. (2003). Perceived risk for type 2 diabetes in participants in a stepwise population screening programme. Diabetic Medicine, 20, 210–215.PubMedCrossRef
13.
Jackson, D. M., Wills, R., Davies, J., Meadows, K., Singh, B. M., & Wise, P. H. (1991). Public awareness of the symptoms of diabetes mellitus. Diabetic Medicine, 8, 971–972.PubMedCrossRef
14.
Farmer, A. J., Levy, J. C., & Turner, R. C. (1999). Knowledge of risk of developing diabetes mellitus among siblings of type 2 patients. Diabetic Medicine, 16, 233–237.PubMedCrossRef
15.
Adriaanse, M. C., Dekker, J. M., Spikerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21(10), 1075–1081.PubMedCrossRef
16.
The Diabetes Prevention Program Research Group. (1999). The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623–634.PubMedCentralCrossRef
17.
The Diabetes Prevention Program Research Group. (2002). The Diabetes Prevention Program: recruitment methods and results. Controlled Clinical Trials, 23, 157–171.CrossRef
18.
The Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393–403.CrossRef
19.
The Diabetes Prevention Program Research Group. (2000). The Diabetes Prevention Program: Baseline characteristics of the randomized cohort. Diabetes Care, 23, 1619–1629.PubMedCentralCrossRef
20.
The Diabetes Prevention Program (DPP) Research Group. (2002). The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care, 25, 623–634.CrossRef
21.
McHorney, C. A., Ware, J. E., & Raczek, A. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.PubMedCrossRef
22.
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13, 873–884.PubMedCrossRef
23.
Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for the two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14(6), 1523–1532.PubMedCrossRef
24.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183–1197.
25.
Fine, J. T., Colditz, G. A., Coakley, E. H., Moseley, G., Manson, J. E., Willett, W. C., et al. (1999). A prospective study of weight change and health-related quality of life in women. The Journal of the American Medical Association, 282, 2136–2142.CrossRef
26.
Kazis, L. E., Miller, D. R., Clark, J., Skinner, K., Lee, A., Rogers, W., et al. (1998). Health-related quality of life in patients served by the Department of Veterans Affairs: Results From the Veterans Health Study. Annals of Internal Medicine, 158(6), 626–632.CrossRef
27.
Kriska, A.M., Caspersen, C.J. (1997). Introduction to the collection of physical activity questionnaires in a collection of physical activity questionnaires for health-related research. In: Kriska, A.M., Caspersen, C.J. (Eds.), Centers for Disease Control and Prevention. Medicine and Science in Sports and Exercise, 29(Supp), S5–S9.
28.
Curran, P. J., Obeidat, K., & Losardo, D. (2010). Twelve frequently asked questions about growth curve modeling. Journal of Cognition and Development, 11(2), 121–136.PubMedCentralPubMedCrossRef
29.
Verbeke, G., & Molenberghs, G. (2009). Linear mixed models for longitudinal data. New York: Springer.
30.
Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404.PubMedCrossRef
31.
Simon, G. E., Revicki, D. A., Grothaus, L., & Vonkorff, M. (1998). SF-36 summary scores: Are physical and mental health truly distinct? Medical Care, 36(4), 567–572.PubMedCrossRef
32.
Tuna, H. D., Edeer, A. O., Malkoc, M., & Aksakoglu, G. (2009). Effects of age and physical activity level on functional fitness in older adults. European Review of Aging and Physical Activity, 6(2), 99–106.CrossRef
33.
Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user’s manual. Boston: The Health Institute, New England Medical Center.
34.
Hopman, W. M., Berger, C., Joseph, L., Towheed, T., VandenKerkhof, E., Anastassiades, T., et al. (2006). The natural progression of health related quality of life: Results of a five-year prospective study of the SF-36 scores in a normative population. Quality of Life Research, 15, 527–536.PubMedCrossRef
Metagegevens
Titel
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study
Auteurs
D. Marrero
Q. Pan
E. Barrett-Connor
M. de Groot
P. Zhang
C. Percy
H. Florez
R. Ackermann
M. Montez
R. R. Rubin
the DPPOS Research Group
Publicatiedatum
01-02-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0436-3

Andere artikelen Uitgave 1/2014

Quality of Life Research 1/2014 Naar de uitgave

OriginalPaper

Evaluation of the similarities and differences in response patterns to the Pediatric Quality of Life Inventory and the Child Oral Health Impact Scores among youth with cleft

OriginalPaper

Necessary and sufficient causes of participation post-stroke: practical and philosophical perspectives

Commentary

Significance, truth and proof of p values: reminders about common misconceptions regarding null hypothesis significance testing

OriginalPaper

The association between motor vehicle injuries and health-related quality of life: a longitudinal study of a population-based sample in the United States

OriginalPaper

Should patients perception of health status be integrated in the prognostic assessment of heart failure patients? A prospective study

Commentary

Innovations in e-health